Exploring Innovative Ideas and New Concepts in Concrete

 

When President of L.L. Geans Construction Rocky Geans attended World of Concrete decades ago, he didn’t expect his entire understanding of concrete to be challenged. But that’s what happened.

Rocky joined the Marketscale Engineering and Construction podcast to discuss new (and storied) innovations in the concrete industry, how they are affecting business, and how he goes about implementing new ideas and practices within a team of employees.

In order to make concrete, you need one key ingredient: water. Though this property makes concrete workable, add too much of it, and concrete becomes brittle. That’s why Water Reducer is such an exciting innovation for concrete pourers. This admixture makes concrete more workable, no matter the weather conditions, without sacrificing concrete stability. Water Reducer allows for a speedier pour, easier placement and a better viscosity of workable poured concrete.

With continued growth awareness for this methodology in the world of concrete, Geans says educating employees on new practices relies solely on the business owner. Take time to ensure everyone understands each part of all new practices.

When investing in innovation within a company, consider putting together an Research & Development team, Geans advised, and make it a diverse mix of employees that work across all aspects of a project.

Most importantly, take care of your people, Geans emphasized. Demonstrate “I need you,” and mean it. When workers feel valued, understood and heard, employees often come up with incredible ideas, Geans said.

For the latest news, videos, and podcasts in the Engineering & Construction Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More